NASDAQ:BCLI

Brainstorm Cell Therapeutics Stock News

etoro logo Buy BCLI
*Your capital is at risk
$0.770
-0.0217 (-2.74%)
At Close: Jun 03, 2026
Maxim Group analyst Jason McCarthy initiated coverage with a Buy rating on Annovis Bio (ANVS – Research Report) today and
There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Armata Pharmaceuticals
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 17) Adverum Biotechnologies Inc...

Researchers make 'self-cleaning' face mask

08:57pm, Wednesday, 17'th Jun 2020
Israeli researchers say they have invented a reusable face mask that can kill the coronavirus with heat by drawing power from a mobile phone charger.
Researchers at Technion University in Israel have invented a reusable face mask that can kill the coronavirus with heat.
Israeli researchers say they have invented a reusable face mask that can kill the coronavirus with heat by drawing power from a mobile phone charger.
Israeli researchers say they have invented a reusable face mask that can kill the coronavirus with heat by drawing power from a mobile phone charger.
Israeli researchers say they have invented a reusable face mask that can kill the coronavirus with heat by drawing power from a mobile phone charger.
Here's a roundup of top developments in the biotech space over the last 24 hour. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 16) ADC Therapeutics SA (NYSE:...
Maxim Group analyst Jason McCarthy assigned a Buy rating to Navidea (NAVB – Research Report) today and set a price
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 16) Applied Molecular Transport...
NEW YORK, June 15, 2020 -- BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of adult stem cell therapies for neurodegenerative diseases, today announced.
The Mighty Pat Quinn is rallying people to raise money for ALS research through his #Handlebars4Hope challenge throughout the month of June.
BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of adult stem cell therapies for neurodegenerative diseases, today announced Chaim Lebovits, CEO and Ralph Kern, MD, MHSc, Preside
By David Bautz, PhD NASDAQ:BCLI READ THE FULL BCLI RESEARCH REPORT Business Update $500,000 Grant from ALS Association and I AM ALS On June 9, 2020, BrainStorm Cell Therapeutics, Inc. (NASDAQ:BCLI) an
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE